Primary Peritoneal Clear Cell Carcinoma
NCI Definition: An extremely rare adenocarcinoma arising from the peritoneum. It is composed of malignant glandular epithelium containing clear cells. 
There are 6 clinical trials for primary peritoneal clear cell carcinoma, of which 5 are open and 1 is completed or closed. Of the trials that contain primary peritoneal clear cell carcinoma as an inclusion criterion, 2 are phase 1 (2 open), 3 are phase 1/phase 2 (2 open), and 1 is phase 2 (1 open).
Carboplatin, paclitaxel, and avb-s6-500 are the most common interventions in primary peritoneal clear cell carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.